An update on novel antiplatelets in vascular patients

Acetylsalicylic acid, clopidogrel and cilostazol are well-established agents inhibiting the normal function of platelets with known advantages and limitations. The development of novel antiplatelet agents aims in providing equal or superior outcomes for patients and simultaneously minimize side effe...

Full description

Saved in:
Bibliographic Details
Published inCurrent pharmaceutical design
Main Authors Patelis, Nikolaos, Kakavia, Kyriaki, Maltezos, Konstantinos, Damascos, Christos, Spartalis, Eleftherios, Matheiken, Sean, Georgopoulos, Sotirios
Format Journal Article
LanguageEnglish
Published United Arab Emirates 01.01.2018
Subjects
Online AccessGet more information

Cover

Loading…